Article

Perspectives of People At-Risk on Parkinson's Prevention Research

2023-12-20

Abstract excerpt

The movement toward prevention trials in people at-risk for Parkinson’s is rapidly becoming a reality. The authors of this article include a genetically at-risk advocate with the LRRK2 G2019S variant and two patients with rapid eye movement sleep behavior disorder (RBD), one of whom has now been diagnosed with Parkinson’s disease (PD). These authors participated as speakers, panelists, and moderators i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 69d91739-e14b-531a-8829-1ca5b30704fb
DOI: 10.20944/preprints202312.1478.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Perspectives of People At-Risk on Parkinson's Prevention ResearchDOI 10.20944/preprints202312.1478.v1Read

Perspectives of People At-Risk on Parkinson's Prevention Research.Semantic proximity Read

Fox Insight Collects Online, Longitudinal Patient-Reported Outcomes and Genetic Data on Parkinson’s diseaseSemantic proximity Read

Parkinson's disease variant detection and disclosure: PD GENEration, a North American study.Semantic proximity Read

Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson's disease.Semantic proximity Read

Disclosure of research results in genetic studies of Parkinson's disease caused by LRRK2 mutations.Semantic proximity Read

A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design.Semantic proximity Read

The Rostock International Parkinson's Disease (ROPAD) Study: Protocol and Initial Findings.Semantic proximity Read

Guidance for clinical management of pathogenic variant carriers at elevated genetic risk for ALS/FTD.Semantic proximity Read

Racial Disparities in Parkinson Disease Clinical Phenotype, Management, and Genetics: Protocol for a Prospective Observational Study.Semantic proximity Read

Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s diseaseSemantic proximity Read

Overcoming challenges to successful recruitment of individuals at the earliest stages of disease: An example from Parkinson’s disease researchSemantic proximity Read

Evaluating Lipid-Lowering Drug Targets for Parkinson's Disease Prevention with Mendelian Randomization.Semantic proximity Read